🕵️ APYX Medical Corp ($APYX)
SEC insider & ownership activity, last 12 months · CIK 719135 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 10.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Wilmot B. Harkey | 10.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Daniel Mack | 10.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Royce & Associates LP | 7.8% | 13G | Jul 21, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 24, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Other events (8.01) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Other events (8.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Other events (8.01) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 17, 2025 | filing ↗ |
| Other events (8.01) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Shareholder vote (5.07) | Aug 7, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |